HomePPLPHARMA • NSE
add
Piramal Pharma Ltd
Previous close
₹208.08
Day range
₹205.80 - ₹209.50
Year range
₹145.25 - ₹307.90
Market cap
272.58B INR
Avg Volume
3.96M
P/E ratio
303.65
Dividend yield
-
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 27.54B | 7.90% |
Operating expense | 14.81B | 66.01% |
Net income | 1.54B | 51.57% |
Net profit margin | 5.57 | 40.30% |
Earnings per share | 1.16 | 33.33% |
EBITDA | 5.12B | 0.81% |
Effective tax rate | 43.73% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.21B | 3.89% |
Total assets | 156.78B | 2.39% |
Total liabilities | 75.52B | 2.05% |
Total equity | 81.25B | — |
Shares outstanding | 1.32B | — |
Price to book | 3.39 | — |
Return on assets | — | — |
Return on capital | 6.20% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.54B | 51.57% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2020
Website
Employees
6,719
